Portolan Capital Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-138,748
| Closed | -$3.35M | – | 145 |
|
|
2025
Q1 | $3.35M | Buy |
138,748
+10,328
| +8% | +$249K | 0.25% | 87 |
|
|
2024
Q4 | $5.17M | Buy |
128,420
+2,658
| +2% | +$107K | 0.35% | 90 |
|
|
2024
Q3 | $7.96M | Buy |
125,762
+46,340
| +58% | +$2.93M | 0.58% | 62 |
|
|
2024
Q2 | $4.21M | Sell |
79,422
-18,161
| -19% | -$963K | 0.35% | 94 |
|
|
2024
Q1 | $8M | Sell |
97,583
-242,217
| -71% | -$19.9M | 0.61% | 63 |
|
|
2023
Q4 | $6.32M | Buy |
+339,800
| New | +$6.32M | 0.55% | 63 |
|